Manifold

Manifold's core business is providing a unified, end-to-end platform for research organizations, with a particular focus on cancer centers and entities involved in rare disease studies. Its client roster includes prominent institutions like the Indiana University Melvin and Bren Simon Comprehensive Cancer Center and the Winship Cancer Institute of Emory University. The business model centers on providing this platform to streamline and automate the historically manual and fragmented workflows of study and data management. By doing so, Manifold aims to significantly reduce research timelines, enabling scientists to move from data collection to insights in a fraction of the time previously required.

The platform is engineered to handle the increasing complexity and volume of healthcare data, which includes information from electronic health records, genetic sequencing, and medical imaging. It consolidates these disparate, multimodal datasets into a single, secure, and analysis-ready environment. Key features include tools for AI-powered cohort exploration, data engineering, bioinformatics, secure collaboration, and study management. A significant benefit for researchers is the ability to interact with complex data through user-friendly interfaces, including natural language queries, without needing to write code. The platform's architecture is designed to be implemented within months, a substantial time-saving compared to building bespoke internal solutions. In April 2024, Manifold announced a $15 million Series A funding round led by TQ Ventures, with participation from Calibrate Ventures and SK Ventures, to expand partnerships and further invest in research and development.